These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10553633)

  • 1. [Enoxaparin in the treatment of acute myocardial infarction].
    Iavelov IS
    Ter Arkh; 1999; 71(9):80-3. PubMed ID: 10553633
    [No Abstract]   [Full Text] [Related]  

  • 2. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
    Antman EM; Morrow DA; McCabe CH; Jiang F; White HD; Fox KA; Sharma D; Chew P; Braunwald E;
    Am Heart J; 2005 Feb; 149(2):217-26. PubMed ID: 15846258
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.
    Murphy SA; Gibson CM; Morrow DA; Van de Werf F; Menown IB; Goodman SG; Mahaffey KW; Cohen M; McCabe CH; Antman EM; Braunwald E
    Eur Heart J; 2007 Sep; 28(17):2077-86. PubMed ID: 17600038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
    Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
    Morrow DA; Antman EM; Murphy SA; Qin J; Ruda M; Guneri S; Jacob AJ; Budaj A; Braunwald E;
    Am Heart J; 2007 Dec; 154(6):1078-84, 1084.e1. PubMed ID: 18035078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis.
    Gabriel RS; White HD
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):851-7. PubMed ID: 17867915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxaparin in patients with primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction.
    Schwarz AK; Zeymer U
    Future Cardiol; 2009 Jan; 5(1):43-9. PubMed ID: 19371202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On "Current role of antithrombotic agents in the treatment of acute coronary syndromes" (Semin Thromb Hemost 2004;30:627-632).
    Nessel CO
    Semin Thromb Hemost; 2005 Apr; 31(2):248. PubMed ID: 15852228
    [No Abstract]   [Full Text] [Related]  

  • 9. The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy.
    Goodman SG; Bozovich GE; Tan M; Dos Santos A; Gurfinkel EP; Cohen M; Langer A;
    Am Heart J; 2006 Apr; 151(4):791-7. PubMed ID: 16569535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy.
    Ray KK; Morrow DA; Gibson CM; Murphy S; Antman EM; Braunwald E
    Eur Heart J; 2005 Mar; 26(5):440-6. PubMed ID: 15673542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial.
    Steinberg BA; Moghbeli N; Buros J; Ruda M; Parkhomenko A; Raju BS; García-Castillo A; Janion M; Nicolau JC; Fox KA; Morrow DA; Gibson CM; Antman EM
    Am Heart J; 2007 Jul; 154(1):54-61. PubMed ID: 17584551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of acute coronary syndromes of the "non-ST elevation" type with enoxaparin: the TIMI 11B study. Thrombolysis in Myocardial Infarct].
    Galli M
    Ital Heart J Suppl; 2000 Apr; 1(4):575-6. PubMed ID: 10832148
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies.
    Spinler SA; Inverso SM; Cohen M; Goodman SG; Stringer KA; Antman EM;
    Am Heart J; 2003 Jul; 146(1):33-41. PubMed ID: 12851605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.
    Kalus JS; Moser LR
    Ann Pharmacother; 2005 Mar; 39(3):481-91. PubMed ID: 15701782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study.
    Marcoff L; Zhang Z; Zhang W; Ewen E; Jurkovitz C; Leguet P; Kolm P; Weintraub WS
    J Am Coll Cardiol; 2009 Sep; 54(14):1271-9. PubMed ID: 19778669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of diabetic patients following acute myocardial infarction: a review of the major thrombolytic trials.
    Jelesoff NE; Feinglos M; Granger CB; Califf RM
    J Cardiovasc Risk; 1997 Apr; 4(2):100-11. PubMed ID: 9304491
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes.
    Cohen M
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E5-9;discussion E25-8. PubMed ID: 11156722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis.
    Giraldez RR; Nicolau JC; Corbalan R; Gurfinkel EP; Juarez U; Lopez-Sendon J; Parkhomenko A; Molhoek P; Mohanavelu S; Morrow DA; Antman EM
    Eur Heart J; 2007 Jul; 28(13):1566-73. PubMed ID: 17562672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombolytic treatment of acute myocardial infarct].
    Luca C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(5):401-12. PubMed ID: 2575270
    [No Abstract]   [Full Text] [Related]  

  • 20. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.